» Articles » PMID: 16889540

CD4+25+ Regulatory T Cells Limit Th1-autoimmunity by Inducing IL-10 Producing T Cells Following Human Lung Transplantation

Overview
Journal Am J Transplant
Publisher Elsevier
Specialty General Surgery
Date 2006 Aug 8
PMID 16889540
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic human lung allograft rejection is manifested by bronchiolitis obliterans syndrome (BOS). BOS has a multifactorial etiology. Previous studies have indicated that both cellular and humoral alloimmunity play a significant role in the pathogenesis of BOS. Recently, autoimmunity has also been demonstrated to contribute to lung allograft rejection in animal models. However, the significance of autoimmunity in BOS remains unknown. In this report, we investigated the role of naturally occurring CD4(+)CD25(+) regulatory T cells (T-regs) in modulating cellular autoimmunity to collagen type V (col-V), a 'sequestered' yet immunogenic self-protein present in the lung tissue, following lung transplantation (LT). We demonstrated that col-V reactive CD4(+) T cells could be detected in the peripheral blood of lung transplant recipients. There was a predominance of IL-10 producing T cells (T(IL-10)) reactive to col-V with significantly lower levels of IFN-gamma and IL-2 producing T cells (Th1 cells). The col-V specific T(IL-10) cells suppressed the proliferation and expansion of col-V specific Th1 cells by IL-10-dependent and contact-independent pathways. The T(IL-10) cells were distinct but their development was dependent on the presence of T-regs. Furthermore, during chronic lung allograft rejection there was a significant decline of T(IL-10) cells with concomitant expansion of col-V-specific IFN-gammaproducing Th1 cells.

Citing Articles

Monitoring regulatory T cells as a prognostic marker in lung transplantation.

Khan M, Lau C, Krupnick A Front Immunol. 2023; 14:1235889.

PMID: 37818354 PMC: 10561299. DOI: 10.3389/fimmu.2023.1235889.


Immune processes in the pathogenesis of chronic lung allograft dysfunction: identifying the missing pieces of the puzzle.

Bos S, Milross L, Filby A, Vos R, Fisher A Eur Respir Rev. 2022; 31(165).

PMID: 35896274 PMC: 9724884. DOI: 10.1183/16000617.0060-2022.


Extracellular Vesicles Mediate Immune Responses to Tissue-Associated Self-Antigens: Role in Solid Organ Transplantations.

Ravichandran R, Bansal S, Rahman M, Sureshbabu A, Sankpal N, Fleming T Front Immunol. 2022; 13:861583.

PMID: 35572510 PMC: 9094427. DOI: 10.3389/fimmu.2022.861583.


Targeting Interleukin-10 Restores Graft Microvascular Supply and Airway Epithelium in Rejecting Allografts.

Kazmi S, Khan M, Shamma T, Altuhami A, Ahmed H, Assiri A Int J Mol Sci. 2022; 23(3).

PMID: 35163192 PMC: 8836023. DOI: 10.3390/ijms23031269.


Auto-inflammation and auto-immunity pathways are associated with emergence of BOS in pediatric lung transplantation.

Conrad C, Hedlin H, Chin H, Hayes Jr D, Heeger P, Faro A Pediatr Transplant. 2022; 26(4):e14247.

PMID: 35146849 PMC: 9086108. DOI: 10.1111/petr.14247.